Takeda Pharmaceutical
TAK
$13.39
Share price
-0.45%
Change (1 day)
-18.95%
Change (1 year)
Categories
Earnings for Takeda Pharmaceutical (TAK)
Earnings in 2023 (TTM): $2.28 B
According to Takeda Pharmaceutical's latest financial reports the company's current earnings (TTM) are $2.28 B. In 2022 the company made an earning of $3.17 B a decrease over its 2021 earnings that were of $5.39 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Takeda Pharmaceutical from 2009 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $2.28 B | -28.11% |
| 2022 | $3.17 B | -41.15% |
| 2021 | $5.39 B | 78.15% |
| 2020 | $3.02 B | 246.83% |
| 2019 | $0.87 B | -48.74% |
| 2018 | $1.70 B | -23.86% |
| 2017 | $2.23 B | 21.77% |
| 2016 | $1.83 B | -253.22% |
| 2015 | -$1.2 B | -159.7% |
| 2014 | $2.00 B | 12.76% |
| 2013 | $1.78 B | 2.7% |
| 2012 | $1.73 B | -57.11% |
| 2011 | $4.04 B | -10.11% |
| 2010 | $4.50 B | -4.2% |
| 2009 | $4.69 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | 835.57% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | 330.36% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | 43.07% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | 244.00% | 🇺🇸 USA |
 Sanofi SNY | $7.26 B | 217.98% | 🇫🇷 France |
 Merck MRK | $3.03 B | 32.91% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.88 B | 201.53% | 🇬🇧 UK |
 Seagen
SGEN | -$0.8 B | -134.62% | 🇺🇸 USA |
 Dr. Reddy's RDY | $0.85 B | -62.60% | 🇮🇳 India |